Sanathkumar Harshavardhan T, Fernando Edwin M, Kurien Anila Abraham, Srinivasaprasad N D, Suren Sujith, Thirumalvalavan K
Department of Nephrology, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India.
Renopath, Center for Renal and Urological Pathology Private Limited, VMT Nagar, Kolathur, Chennai, Tamil Nadu, India.
Indian J Nephrol. 2022 Nov-Dec;32(6):546-554. doi: 10.4103/ijn.IJN_470_20. Epub 2022 Nov 21.
Infection-related glomerulonephritis (IRGN) is an important source of renal morbidity with adverse outcomes in adults. Data from large centers in India is lacking on this common, yet poorly understood entity.
We performed a prospective observational study of all patients diagnosed with IRGN at our center over a 3-year period between 2017 and 2019. "Typical IRGN" patients were diagnosed based on clinical and laboratory assessment; others underwent renal biopsy. Renal and patient survival outcomes were assessed in addition to factors that help predict outcomes.
One hundred and twenty-five patients with a diagnosis of IRGN were included in the study, including 86 patients who underwent renal biopsy. This represented 24% of all biopsies during this time period, and IRGN was the most common nondiabetic kidney disease identified in diabetic biopsies at our center. Female preponderance and a seasonal variation were striking. Atypical sources of infection like otomycosis, tooth abscess, and dengue virus infection were noted. Male gender and diabetes were important risk factors for severe disease. Rapidly progressive glomerulonephritis (RPGN), atypical serum complement profiles, and comorbid illnesses were common in adults. Though children had more benign disease and outcomes, life-threatening complications were also noted. C3 dominance was the most striking immunofluorescence (IF) finding and was associated with poorer outcomes. Crescentic IRGN was rare, and four cases of IgA-dominant IRGN were noted. Also, 24% of the cohort required renal replacement therapy. RPGN presentation of IRGN portended worst prognosis with end-stage renal disease (ESRD) in 31% and death in 22% of patients.
IRGN is a common clinical entity in adults with the potential for adverse renal and survival outcomes. We have identified clinical and biopsy characteristics that are associated with ESRD and death.
感染相关性肾小球肾炎(IRGN)是成人肾脏发病的重要原因,可导致不良后果。印度大型中心缺乏关于这个常见但了解不足的疾病实体的数据。
我们对2017年至2019年期间在本中心诊断为IRGN的所有患者进行了一项前瞻性观察研究。“典型IRGN”患者根据临床和实验室评估进行诊断;其他患者接受肾活检。除了有助于预测预后的因素外,还评估了肾脏和患者的生存结局。
125例诊断为IRGN的患者纳入研究,其中86例接受了肾活检。这占该时间段内所有活检的24%,IRGN是我们中心糖尿病患者活检中最常见的非糖尿病肾病。女性占优势和季节性变化显著。注意到感染的非典型来源,如耳霉菌病、牙脓肿和登革热病毒感染。男性和糖尿病是严重疾病的重要危险因素。快速进展性肾小球肾炎(RPGN)、非典型血清补体谱和合并症在成人中很常见。虽然儿童的疾病和结局更良性,但也注意到危及生命的并发症。C3优势是最显著的免疫荧光(IF)发现,与较差的结局相关。新月形IRGN罕见,注意到4例IgA为主的IRGN。此外,24%的队列需要肾脏替代治疗。IRGN的RPGN表现预示着最差的预后,31%的患者发展为终末期肾病(ESRD),22%的患者死亡。
IRGN是成人常见的临床疾病,有可能导致不良的肾脏和生存结局。我们已经确定了与ESRD和死亡相关的临床和活检特征。